2005, Volume 12, Issue 04, pages 245-320

Coronary heart disease (CHD) is the most common cause of death in the UK; one in four men and one in six women will die...

Treatments for heart failure include digoxin, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, aldosterone antagonists and beta blockers. Beta blockers have been contra-indicated until fairly...

This article describes the diagnosis, classification and management of atrial fibrillation (AF) in primary care. It looks at its increasing incidence, its risk factors, and...

The plasminogen activator inhibitors have an important therapeutic role in controlling bleeding in patients with congenital and acquired coagulation disorders. They are being increasingly used...

This study set out to evaluate the completeness of medical records of chest pain. A planned, multicentre, structured abstraction of data from case-notes was made...

Tailoring healthcare provision to fulfil patients' needs is a principal objective of health services. Data on needs are sparse, especially in patients with coronary heart...

The efficacy and tolerability of two candesartan treatment regimens were evaluated in 578 severely hypertensive patients already receiving a diuretic plus an angiotensin-converting enzyme (ACE)...

The plasminogen activator inhibitors have an important therapeutic role in controlling bleeding in patients with congenital and acquired coagulation disorders. They are being increasingly used...

Atherosclerotic cardiovascular disease (CVD) is common in patients with diabetes, and antiplatelet therapy has been the cornerstone of preventative therapy for many years. The majority...

A new analysis of the LIFE study has shown that losartan can reduce new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy. General practitioner...

The association between mitral valve disease, atrial fibrillation (AF) and the incidence of embolic stroke is well known. The incidence of systemic embolism (including embolic...

Health risk is not synonymous with obesity and obesity is not synonymous with visceral fat. Obesity is now recognised by governments, and importantly in medical...